CAN BAICALEIN BECOME A NEW DRUG FOR COVID-19?
- 3 December 2021
- journal article
- Published by Faculty of Military Health Sciences, University of Defence in Military Medical Science Letters
- Vol. 90 (4) , 198-207
Abstract
No abstract availableThis publication has 78 references indexed in Scilit:
- Chinese Medicine Injection Shuanghuanglian for Treatment of Acute Upper Respiratory Tract Infection: A Systematic Review of Randomized Controlled TrialsEvidence-Based Complementary and Alternative Medicine, 2013
- Baicalein, Ethyl Acetate, and Chloroform Extracts ofScutellaria baicalensisInhibit the Neuraminidase Activity of Pandemic 2009 H1N1 and Seasonal Influenza A VirusesEvidence-Based Complementary and Alternative Medicine, 2013
- Antiviral Activity of Baicalein and Quercetin against the Japanese Encephalitis VirusInternational Journal of Molecular Sciences, 2012
- Novel antiviral activity of baicalein against dengue virusBMC Complementary and Alternative Medicine, 2012
- Computational investigation of the Anti-HIV activity of Chinese medicinal formula Three-Huang PowderInterdisciplinary Sciences: Computational Life Sciences, 2010
- Baicalin, an emerging multi-therapeutic agent: pharmacodynamics, pharmacokinetics, and considerations from drug development perspectivesXenobiotica, 2010
- Increased Oral AUC of Baicalin in Streptozotocin-Induced Diabetic Rats due to the Increased Activity of Intestinal β-GlucuronidasePlanta Medica, 2009
- In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compoundsJournal of Clinical Virology, 2004
- Sho‐saiko‐to: Japanese herbal medicine for protection against hepatic fibrosis and carcinomaJournal of Gastroenterology and Hepatology, 2000
- Effects of Kampo (Japanese Herbal) Medicine “Sho-Saiko-To” on DNA-Synthesizing Enzyme Activity in 1,2-Dimethylhydrazine-Induced Colonic Carcinomas in RatsPlanta Medica, 1993